Clinical trial

NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus…

NCT00322465 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00322465
Title NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)
Official title Phase II Randomized, Placebo-Controlled Double-Blind 4-Arm Trial for the Treatment of Non-Gonococcal Urethritis (NGU): Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Urethritis
Intervention type Drug, Other
Interventions Tinidazole, Placebo, Doxycycline, Azithromycin
Enrollment 305
Start date Nov 1, 2006
Primary completion Apr 1, 2009
Completion Apr 1, 2009
First posted May 8, 2006
Last update posted Mar 1, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies